Intravenous lipid emulsion in the management of amlodipine overdose

Hospital Pharmacy

Volumn 48, Issue 10, 2013, Pages 848-854

  Meaney, Calvin ^a   Sareh, Houtan ^b   Hayes, Bryan ^b   Gonzales, Jeffrey ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

amlodipine; calcium channel blocker; lipid emulsion; overdose; toxicology

Indexed keywords

ACTIVATED CARBON; ALANINE AMINOTRANSFERASE; AMLODIPINE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CALCIUM CHLORIDE; GLUCAGON; GLUCONATE CALCIUM; INFUSION FLUID; INTRALIPID; NORADRENALIN; OXYHEMOGLOBIN; PHENYLEPHRINE; PIG INSULIN; VASOPRESSIN;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; BREATHING RATE; CARDIOPULMONARY HEMODYNAMICS; CASE REPORT; DELIRIUM TREMENS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG INTOXICATION; DRUG OVERDOSE; ELECTROCARDIOGRAM; EMERGENCY HEALTH SERVICE; EXPOSURE; FEMALE; HEART RATE; HOME CARE; HUMAN; HYPOTENSION; INTENSIVE CARE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; MITRAL VALVE PROLAPSE; PATIENT; PH; PHYSICAL EXAMINATION; POSTTRAUMATIC STRESS DISORDER; SHOCK; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME;

EID: 84887428168     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4810-848     Document Type: Article

References (30)

1. Brontein A, Spyker D, Cantilena L, Green J, Rumack B, Dart R. 2010 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th annual report. Clin Toxicol. 2010;49:910-941.
2. Hedge M. Calcium channel blocker toxicology. J Pharm Pract. 2005;18:169-174.
3. Scholz H. Pharmacological aspects of calcium channel blockers. Cardiovasc Drugs Ther. 1997;10:869-887.
4. Schwartz DAJ. Calcium-antagonist drugs. N Engl J Med. 1999;341:1447-1457.
5. DeWitt C, Waksman J. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004;23:223-238.
6. Laine K, Laakso KKI, Neuvonen P. Prevention of amlodipine absorption by activated charcoal: Effect of delay in charcoal administration. Br J Clin Pharmacol. 1997;43:29-33.
7. Hung Y, Olson K. Acute amlodipine overdose treated by high dose intravenous calcium in a patient with severe renal insufficiency. Clin Toxicol. 2007;45:301-303.
8. Lam Y, Lau HTC. Continuous calcium chloride infusion for massive nifedipine overdose. Chest. 2001;119:1280-1282.
9. Harris N. Case 24-2006: A woman with hypotension after an overdose of amlodipine. N Engl J Med. 2006;355: 602-311.
10. Hoek TV, Morrison L, Shuster M, et al. Part 12: Cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:S829-S861.
11. Engebretsen K, Kaczmarek K, Morgan J. JSHolger. Highdose insulin therapy in beta-blocker and calcium channelblocker poisoning. Clin Toxicol. 2011;49:277-283.
12. Greene S, Gawarammana I, Wood D, Jones A, Dargan P. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: A prospective observational study. Intens Care Med. 2007;33: 2019-2024.
13. Holger J, Stellpflug S, Cole J, Harris C, Engebretsen K. High-dose insulin: A consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol. 2011;49:653-658.
14. Patel N, Pugh M, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy for verapamil poisoning: A review. Am J Crit Care. 2007;16:489-503.
15. Shepherd G, Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother. 2005;39:923-930.
16. Cole J, Engebretsen K, Stellpflug S, et al. 10 U/kg/hr of high dose insuliun is superior to 1 U/kg/hr in a blinded, randomized, controlled trial in poison-induced cardiogenic shock [abstract]. Clin Toxicol. 2011;49:515.
17. Weinberg G. Lipid rescue resuscitation from local anaesthetic cardiac toxicity. Toxicol Rev. 2006;25:139-145.
18. Weinberg G Lipid emulsion infusion: Resuscitation for local anesthetic and other drug overdose. Anesthesiology. 2012;117:180-187.
19. Nelson R, Prasad A, Lerman A, Miles J. Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes. 2007;56:527-530.
20. Turner-Lawrence D, Kerns LW. Intravenous fat emulsion: a potential novel antidote. J Med Toxicol. 2008;4:109-114.
21. Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: A systematic review. Acad Emerg Med. 2009;16:815-824.
22. Delgado JN, Remers WA. Calculated log P, log D, and pKa [appendix]. In: Beale JM, Block JH, eds. Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:976-988.
23. Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny J. Lipid emulsions in the treatment of acute poisoning: A systematic review of human and animal studies. Clin Toxicol. 2010;48:1-27.
24. ACMT position statement: Interim guidance for the use of lipid resuscitation therapy. J Med Toxicol. 2011;7:81-82.
25. Orr K, Bailie R. The use of Intralipid in the management of a mixed overdose. J Intens Care Soc. 2010;11:268-269.
26. West P, McKeown N, Hendrickson R. Iatrogenic lipid emulsion overdose in a case of amlodipine poisoning. Clin Toxicol. 2010;48:393-396.
27. Geib A, Manini A, Liebelt E. Case series of intravenous lipid emulsion rescue for drug cardiotoxicity [abstract]. Clin Toxicol. 2009;47:704.
28. Naranjo C, Busto U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
29. Grunbaum AM, Gilfix BM, Gosselin S, Blank DW. Analytical interferences resulting from intravenous lipid emulsion. Clin Toxicol. 2012;50:812-817.
30. Intralipid [package insert]. Uppsala, Sweden: Fresenius Kabi; 2007.